Financhill
Back

scPharmaceuticals Quote, Financials, Valuation and Earnings

Yours Free! Top SIX AI Dividend Stocks Right Now

NO CREDIT CARD REQUIRED!
Sell
45

SCPH
scPharmaceuticals

Last Price:
4.21
Seasonality Move:
0.15%

7 Day Trial

ALL ACCESS PASS

$ 7

The Mysterious VC Firm Behind Nvidia's Secret Weapon

Details Here!

scPharmaceuticals Price Quote

$4.21
+0.00 (+-2.55%)
(Updated: November 9, 2024 at 5:45 AM ET)

scPharmaceuticals Key Stats

Sell
45
scPharmaceuticals (SCPH) is a Sell

Day range:
$4.18 - $4.40
52-week range:
$3.24 - $6.71
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
6.80
P/B ratio:
22.74%

Volume:
176.1K
Avg. volume:
238.7K
1-year change:
-18.35%
Market cap:
$210.4M
Revenue:
$13.6M
EPS:
$-1.56

How Much Does scPharmaceuticals Make?

Is scPharmaceuticals Growing As A Company?

  • What Is scPharmaceuticals's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 3.92%
  • What Is scPharmaceuticals's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

scPharmaceuticals Stock Price Performance

What Is scPharmaceuticals 52-Week High & Low?

scPharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy scPharmaceuticals?

  • How Much Debt Does scPharmaceuticals Have?
    Total long term debt quarterly is $40M
  • How Much Cash Does scPharmaceuticals Have?
    Cash and short term investments quarterly total is $38.5M
  • What Is scPharmaceuticals’s Book Value Per Share?
    Book value per share is 0.26

Is scPharmaceuticals Cash Flow Positive?

  • What Is SCPH Cash Flow From Operations?
    Cash flow from operations (TTM) is -$66.5M
  • What Is scPharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $833K
  • What Is scPharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $32.9M

scPharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    SCPH return on invested capital is -80.26%
  • What Is scPharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is -66.11%
  • What Is SCPH Return On Equity?
    ROE is a measure of profitability and is -165.15%

scPharmaceuticals Earnings Date & Stock Price

scPharmaceuticals Competitors

  • Who Are scPharmaceuticals's Competitors?
    Below is a list of companies who compete with scPharmaceuticals or are related in some way:
    • iBio Inc (IBIO)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Oragenics Inc (OGEN)
    • Palatin Technologies Inc (PTN)
    • Theriva Biologics Inc (TOVX)

scPharmaceuticals Dividend Yield

scPharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -6.28%
Revenue: 391.7% 1.06%

Analyst Recommendations

Buy Recommendations: 4
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 19.17
Upside from Last Price: 355.81%

Major Shareholders

  • How many SCPH shares are owned by institutional investors?
    42M SCPH shares are owned by institutional investors
  • How many SCPH shares are owned by insiders?
    400.9K SCPH shares are owned by insiders